Visualitza VHIO - Articles científics per matèria "Anomalies cromosòmiques"
Ara mostrant els elements 1-20 d 49
-
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
(Oxford University Press, 2023-03) -
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers
(Nature Portfolio, 2022-11-07) -
BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy
(Nature Portfolio, 2022-11-19) -
BRAFV600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
(Oxford University Press, 2023-09-07) -
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
(American Association for Cancer Research, 2023-05-15) -
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
(Frontiers Media, 2023-01-25) -
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
(Nature Portfolio, 2023-05) -
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
(Nature Portfolio, 2024-01) -
eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability
(AME Publishing, 2023-12-26) -
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
(American Society of Hematology, 2023-01-12) -
Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
(MDPI, 2021-04-27) -
Genetic immune escape landscape in primary and metastatic cancer
(Nature Portfolio, 2023-05)